KRAS and neoplasm: Mutated KRAS results in a continuously activated GTP-bound state where the GAP deactivation protein is deemed obsolete and essentially allows the persistent binding of effector proteins, such as PI3K and RAF, to bind and transmit the growth signals downstream to the nucleus to perpetually stimulate tumor growth [131,134,137].